Advancing global livestock solutions: Phibro's portfolio growth

Phibro Animal Health made a landmark move in the animal health industry with its recent acquisition of the medicated feed additive product portfolio and certain water-soluble products from Zoetis, Inc. This pivotal expansion marks a significant advancement in fulfilling the company's mission of optimizing global animal health for a more sustainable world.During our conversation at the World Pork Expo with Scott Fry, Director of Swine Business, and Larry Miller, Chief Operating Officer, we explored how this acquisition transforms Phibro's capabilities. The newly expanded portfolio brings scientifically validated products marketed in approximately 100 countries worldwide under Phibro's umbrella, complementing it existing offerings.What makes this development particularly exciting for swine producers is the comprehensive coverage it now provides across the entire production cycle. Phibro has traditionally excelled in solutions for the sow and nursery phases, but can now deliver expert support from birth through finishing. This complete approach combines medicated feed additives, branded nutrition products, customized autogenous vaccines, and mineral nutrition solutions —allowing producers to implement more integrated health management strategies tailored to its specific challenges.Discover how Phibro's expanded capabilities could transform your approach to livestock health management by visiting www.pahc.com or connecting with a Phibro representative.